Lord, Abbett & Co. LLC Abb Vie Inc. Transaction History

Lord, Abbett & Co. LLC

$29.9 Billion
Q2 2024

A detailed history of Lord, Abbett & Co. LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Lord, Abbett & Co. LLC holds 1,777,221 shares of ABBV stock, worth $344 Million. This represents 1.02% of its overall portfolio holdings.

Number of Shares

1,777,221

Previous 1,751,209 1.49%

Holding current value

$344 Million

Previous $319 Million 4.41%

% of portfolio

1.02%

Previous 1.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $4.03 Million - $4.7 Million	26,012 Added 1.49%	1,777,221 $305 Million
Q1 2024 May 09, 2024	SELL	$159.82 - $182.1 $4.02 Million - $4.58 Million	-25,171 Reduced 1.42%	1,751,209 $319 Million
Q4 2023 Feb 12, 2024	SELL	$137.6 - $154.97 $28.1 Million - $31.6 Million	-203,968 Reduced 10.3%	1,776,380 $275 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $12.3 Million - $14.3 Million	-92,439 Reduced 4.46%	1,980,348 $295 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $170,407 - $212,061	1,286 Added 0.06%	2,072,787 $279 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $8.5 Million - $9.79 Million	-58,795 Reduced 2.76%	2,071,501 $330 Million
Q4 2022 Feb 10, 2023	SELL	$138.31 - $165.87 $6.01 Million - $7.21 Million	-43,456 Reduced 2.0%	2,130,296 $344 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $9.71 Million - $11.1 Million	-72,358 Reduced 3.22%	2,173,752 $292 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $64.2 Million - $81.7 Million	-466,822 Reduced 17.21%	2,246,110 $344 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $1.76 Million - $2.19 Million	13,365 Added 0.5%	2,712,932 $440 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $19.2 Million - $24.3 Million	178,734 Added 7.09%	2,699,567 $366 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $58.6 Million - $66.5 Million	550,459 Added 27.94%	2,520,833 $272 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $14.3 Million - $16 Million	-136,220 Reduced 6.47%	1,970,374 $222 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $7.84 Million - $8.63 Million	76,631 Added 3.77%	2,106,594 $228 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $14.2 Million - $19.2 Million	176,949 Added 9.55%	2,029,963 $218 Million
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $27.7 Million - $32.5 Million	322,249 Added 21.05%	1,853,014 $162 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $24 Million - $32.1 Million	327,450 Added 27.21%	1,530,765 $150 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $4.91 Million - $7.44 Million	76,060 Added 6.75%	1,203,315 $91.7 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $58.7 Million - $73.4 Million	813,549 Added 259.33%	1,127,255 $99.8 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $736,866 - $885,924	-11,700 Reduced 3.6%	313,706 $23.8 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $65,700 - $83,980	-1,000 Reduced 0.31%	325,406 $23.7 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $9.95 Million - $11.7 Million	-129,000 Reduced 28.33%	326,406 $26.3 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $1.07 Million - $1.32 Million	-13,800 Reduced 2.94%	455,406 $42 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $17 Million - $18.9 Million	-191,200 Reduced 28.95%	469,206 $44.4 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $76.9 Million - $91 Million	-856,775 Reduced 56.47%	660,406 $61.2 Million
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $20.4 Million - $27.3 Million	-221,925 Reduced 12.76%	1,517,181 $144 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $5.14 Million - $5.64 Million	-57,400 Reduced 3.2%	1,739,106 $168 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $10.9 Million - $13.9 Million	155,488 Added 9.48%	1,796,506 $160 Million
Q2 2017 Aug 14, 2017	BUY	N/A	1,641,018	1,641,018 $119 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lord, Abbett & Co. LLC with notifications on news.

Account

Lord, Abbett & Co. LLC Abb Vie Inc. Transaction History